MORETTI, GABRIELLA
 Distribuzione geografica
Continente #
NA - Nord America 87
EU - Europa 22
AS - Asia 1
Totale 110
Nazione #
US - Stati Uniti d'America 87
IT - Italia 12
FR - Francia 5
DE - Germania 2
AE - Emirati Arabi Uniti 1
FI - Finlandia 1
GB - Regno Unito 1
RU - Federazione Russa 1
Totale 110
Città #
Fairfield 15
Ashburn 11
Palermo 8
Santa Cruz 8
Seattle 7
Des Moines 6
Wilmington 6
Buffalo 4
San Diego 4
Ann Arbor 3
Cambridge 3
Houston 3
Woodbridge 3
Lentini 2
Boardman 1
Büdelsdorf 1
Crugers 1
Denver 1
Falkenstein 1
Helsinki 1
Las Vegas 1
Saint Petersburg 1
Totale 91
Nome #
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial, file e3ad8923-287b-da0e-e053-3705fe0a2b96 104
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study, file e3ad891d-35f9-da0e-e053-3705fe0a2b96 5
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies, file e3ad891f-1d1e-da0e-e053-3705fe0a2b96 2
Totale 111
Categoria #
all - tutte 334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 334


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/20201 0 0 0 0 0 0 0 0 0 0 1 0
2020/202155 0 0 0 0 31 7 3 5 1 5 1 2
2021/202221 2 3 0 0 1 2 1 0 1 2 7 2
2022/202322 0 1 8 2 2 1 5 1 0 0 2 0
2023/202410 0 0 1 1 0 1 3 3 1 0 0 0
Totale 111